These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22806885)

  • 41. Inhibition of LOX by flavonoids: a structure-activity relationship study.
    Ribeiro D; Freitas M; Tomé SM; Silva AM; Porto G; Cabrita EJ; Marques MM; Fernandes E
    Eur J Med Chem; 2014 Jan; 72():137-45. PubMed ID: 24368208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. COX, LOX and platelet aggregation inhibitory properties of Lauraceae neolignans.
    Coy ED; Cuca LE; Sefkow M
    Bioorg Med Chem Lett; 2009 Dec; 19(24):6922-5. PubMed ID: 19880317
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of antioxidant and inhibitory activities for different subclasses flavonoids on enzymes for rheumatoid arthritis.
    Lee JH; Kim GH
    J Food Sci; 2010 Sep; 75(7):H212-7. PubMed ID: 21535545
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chamazulene: an antioxidant-type inhibitor of leukotriene B4 formation.
    Safayhi H; Sabieraj J; Sailer ER; Ammon HP
    Planta Med; 1994 Oct; 60(5):410-3. PubMed ID: 7997466
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-CD45 antibody enhances lipoxygenase pathway of human naïve mononuclear cells and cyclooxygenase pathway of neutrophils.
    Wu CH; Hsieh SC; Yu HS; Lee KJ; Lu MC; Tsai CY; Yu CL
    Inflamm Res; 2006 Mar; 55(3):92-8. PubMed ID: 16673151
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of nitric oxide-synthase and cyclooxygenase/lipooxygenase systems in development of experimental ulcerative colitis.
    Sklyarov AY; Panasyuk NB; Fomenko IS
    J Physiol Pharmacol; 2011 Feb; 62(1):65-73. PubMed ID: 21451211
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pyrazol-3-propanoic acid derivatives as novel inhibitors of leukotriene biosynthesis in human neutrophils.
    Calışkan B; Luderer S; Özkan Y; Werz O; Banoglu E
    Eur J Med Chem; 2011 Oct; 46(10):5021-33. PubMed ID: 21868137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-throughput screening assays for cyclooxygenase-2 and 5-lipoxygenase, the targets for inflammatory disorders.
    Kumar KA; Reddy TC; Reddy GV; Reddy DB; Mahipal SV; Sinha S; Gaikwad AN; Reddanna P
    Indian J Biochem Biophys; 2011 Aug; 48(4):256-61. PubMed ID: 22053694
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fuscoside: an anti-inflammatory marine natural product which selectively inhibits 5-lipoxygenase. Part II: Biochemical studies in the human neutrophil.
    Jacobson PB; Jacobs RS
    J Pharmacol Exp Ther; 1992 Aug; 262(2):874-82. PubMed ID: 1323665
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic transformation has a profound effect on anti-inflammatory activity of flavonoids such as quercetin: lack of association between antioxidant and lipoxygenase inhibitory activity.
    Loke WM; Proudfoot JM; Stewart S; McKinley AJ; Needs PW; Kroon PA; Hodgson JM; Croft KD
    Biochem Pharmacol; 2008 Mar; 75(5):1045-53. PubMed ID: 18096136
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design, synthesis and biological evaluation of benzo[1.3.2]dithiazolium ylide 1,1-dioxide derivatives as potential dual cyclooxygenase-2/5-lipoxygenase inhibitors.
    Tan CM; Chen GS; Chen CS; Chang PT; Chern JW
    Bioorg Med Chem; 2011 Nov; 19(21):6316-28. PubMed ID: 21958737
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 2-Styrylchromones: novel strong scavengers of reactive oxygen and nitrogen species.
    Gomes A; Fernandes E; Silva AM; Santos CM; Pinto DC; Cavaleiro JA; Lima JL
    Bioorg Med Chem; 2007 Sep; 15(18):6027-36. PubMed ID: 17624791
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 2,3-Diarylxanthones as Potential Inhibitors of Arachidonic Acid Metabolic Pathways.
    Santos CMM; Ribeiro D; Silva AMS; Fernandes E
    Inflammation; 2017 Jun; 40(3):956-964. PubMed ID: 28285462
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulation of human neutrophils' oxidative burst by flavonoids.
    Ribeiro D; Freitas M; Tomé SM; Silva AM; Porto G; Fernandes E
    Eur J Med Chem; 2013 Sep; 67():280-92. PubMed ID: 23871908
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Computer-aided discovery of anti-inflammatory thiazolidinones with dual cyclooxygenase/lipoxygenase inhibition.
    Geronikaki AA; Lagunin AA; Hadjipavlou-Litina DI; Eleftheriou PT; Filimonov DA; Poroikov VV; Alam I; Saxena AK
    J Med Chem; 2008 Mar; 51(6):1601-9. PubMed ID: 18311898
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Essential structural profile of a dual functional inhibitor against cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and 3D-QSAR analyses on DHDMBF analogues.
    Zheng M; Zhang Z; Zhu W; Liu H; Luo X; Chen K; Jiang H
    Bioorg Med Chem; 2006 May; 14(10):3428-37. PubMed ID: 16458008
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antioxidant effect of sulphurous thermal water on human neutrophil bursts: chemiluminescence evaluation.
    Braga PC; Sambataro G; Dal Sasso M; Culici M; Alfieri M; Nappi G
    Respiration; 2008; 75(2):193-201. PubMed ID: 17804898
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
    Rao PN; Chen QH; Knaus EE
    J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of COXs and 5-LOX and activation of PPARs by Australian Clematis species (Ranunculaceae).
    Li RW; Lin GD; Leach DN; Waterman PG; Myers SP
    J Ethnopharmacol; 2006 Mar; 104(1-2):138-43. PubMed ID: 16207522
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-inflammatory potential of 2-styrylchromones regarding their interference with arachidonic acid metabolic pathways.
    Gomes A; Fernandes E; Silva AM; Pinto DC; Santos CM; Cavaleiro JA; Lima JL
    Biochem Pharmacol; 2009 Jul; 78(2):171-7. PubMed ID: 19464432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.